BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 33826098)

  • 1. Polycystic Ovary Syndrome: the Epigenetics Behind the Disease.
    Eiras MC; Pinheiro DP; Romcy KAM; Ferriani RA; Reis RMD; Furtado CLM
    Reprod Sci; 2022 Mar; 29(3):680-694. PubMed ID: 33826098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epigenetics of polycystic ovary syndrome].
    Concha C F; Sir P T; Recabarren SE; Pérez B F
    Rev Med Chil; 2017 Jul; 145(7):907-915. PubMed ID: 29182200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Genetics, Epigenetics and Lifestyle in Polycystic Ovary Syndrome Development: the State of the Art.
    Bruni V; Capozzi A; Lello S
    Reprod Sci; 2022 Mar; 29(3):668-679. PubMed ID: 33709373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic/circadian clocks and PCOS.
    Vatier C; Christin-Maitre S
    Hum Reprod; 2024 Jun; 39(6):1167-1175. PubMed ID: 38600622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation in polycystic ovary syndrome: Emerging evidence and challenges.
    Liu YN; Qin Y; Wu B; Peng H; Li M; Luo H; Liu LL
    Reprod Toxicol; 2022 Aug; 111():11-19. PubMed ID: 35562068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic, hormonal and metabolic aspects of PCOS: an update.
    De Leo V; Musacchio MC; Cappelli V; Massaro MG; Morgante G; Petraglia F
    Reprod Biol Endocrinol; 2016 Jul; 14(1):38. PubMed ID: 27423183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation in the pathogenesis of polycystic ovary syndrome.
    Vázquez-Martínez ER; Gómez-Viais YI; García-Gómez E; Reyes-Mayoral C; Reyes-Muñoz E; Camacho-Arroyo I; Cerbón M
    Reproduction; 2019 Jul; 158(1):R27-R40. PubMed ID: 30959484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic Ovary Syndrome-Epigenetic Mechanisms and Aberrant MicroRNA.
    Ilie IR; Georgescu CE
    Adv Clin Chem; 2015; 71():25-45. PubMed ID: 26411410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial dysfunction: An emerging link in the pathophysiology of polycystic ovary syndrome.
    Shukla P; Mukherjee S
    Mitochondrion; 2020 May; 52():24-39. PubMed ID: 32081727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial epigenetic modifications and nuclear-mitochondrial communication: A new dimension towards understanding and attenuating the pathogenesis in women with PCOS.
    Shukla P; Melkani GC
    Rev Endocr Metab Disord; 2023 Apr; 24(2):317-326. PubMed ID: 36705802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathomechanisms of polycystic ovary syndrome: Multidimensional approaches.
    Sagvekar P; Dadachanji R; Patil K; Mukherjee S
    Front Biosci (Elite Ed); 2018 Mar; 10(3):384-422. PubMed ID: 29293465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which origin for polycystic ovaries syndrome: Genetic, environmental or both?
    Fenichel P; Rougier C; Hieronimus S; Chevalier N
    Ann Endocrinol (Paris); 2017 Jul; 78(3):176-185. PubMed ID: 28606381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.
    Sarahian N; Sarvazad H; Sajadi E; Rahnejat N; Eskandari Roozbahani N
    Reprod Health; 2021 Jul; 18(1):156. PubMed ID: 34311759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of microRNA in the Pathogenesis of Polycystic Ovary Syndrome.
    Chen Z; Ou H; Wu H; Wu P; Mo Z
    DNA Cell Biol; 2019 Aug; 38(8):754-762. PubMed ID: 31305133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Marks in Polycystic Ovary Syndrome.
    Motta AB
    Curr Med Chem; 2020; 27(39):6727-6743. PubMed ID: 31580245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances.
    Spritzer PM
    Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):182-7. PubMed ID: 24830595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovary syndrome in men: Stein-Leventhal syndrome revisited.
    Kurzrock R; Cohen PR
    Med Hypotheses; 2007; 68(3):480-3. PubMed ID: 17134841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.